A Clinical Study on the Antihypertensive Effects of Lasix(R) Retard 30.
10.4070/kcj.1980.10.1.65
- Author:
Yun Shik CHOI
;
Young Woo LEE
- Publication Type:Original Article
- MeSH:
Antihypertensive Agents;
Blood Pressure;
Capsules;
Dizziness;
Female;
Furosemide;
Humans;
Hypertension;
Male;
Outpatients;
Sleep Stages
- From:Korean Circulation Journal
1980;10(1):65-69
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The antihypertensive action of Lasix(R) retard 30 was evaluated in 20 cases of essential hypertension on an outpatient basis. The following results were obtained. 1. The patient population comprised 11 males and 9 females, aged 32 to 67 years, with mild to moderate essential hypertension. mean age was 50 years, with 75% between 40 and 59 years of age. 2. The daily effective doses ranged from 1 to 3 capsules with an average of 1.7 capsules. The total duration of medication ranged from 4 to 12 weeks with an average of 6.5 weeks. 3. In 60% of the cases, good or fair control of blood pressure was resulted. Most of the poor results were in the cases of moderate hypertension, but the results could be improved with continuous treatment or combination with other antihypertensive drugs. 4. Transient dizziness and drowsiness were complained by 2 patients, but subsided spontaneously with continuous treatment. 5. In view of these results, Lasix retard 30 appears to be effective and well tolerated agent for the treatment of mild to moderate hypertension, either used alone or combined with other antihypertensive drugs.
